Published in J Neurol Sci on February 14, 2012
Influence of Exercise on Patients with Guillain-Barré Syndrome: A Systematic Review. Physiother Can (2016) 0.82
Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting. Ann Indian Acad Neurol (2014) 0.81
Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy. BMC Neurol (2015) 0.75
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet (2008) 2.58
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 1.95
Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain (2008) 1.94
PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet (2012) 1.91
Functional recovery measures for spinal cord injury: an evidence-based review for clinical practice and research. J Spinal Cord Med (2008) 1.81
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet (2003) 1.65
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg (2011) 1.42
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
Computer-based, personalized cognitive training versus classical computer games: a randomized double-blind prospective trial of cognitive stimulation. Neuroepidemiology (2011) 1.26
Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord (2007) 1.26
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord (2006) 1.13
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Mov Disord (2007) 1.11
White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Magn Reson Imaging (2005) 1.09
Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (2002) 1.03
Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol (2005) 1.00
Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord (2009) 0.98
Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia (2004) 0.98
Sexual dysfunction in Parkinson's disease. J Sex Marital Ther (2004) 0.98
Smoking and tea consumption delay onset of Parkinson's disease. Parkinsonism Relat Disord (2008) 0.97
Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord (2010) 0.97
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol (2010) 0.96
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice. Prog Neurobiol (2002) 0.96
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry (2010) 0.94
Reliability of the Catz-Itzkovich Spinal Cord Independence Measure assessment by interview and comparison with observation. Am J Phys Med Rehabil (2003) 0.94
Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus. J Child Neurol (2013) 0.93
Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain (2009) 0.93
TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation. Epilepsy Res (2013) 0.92
Homocysteine, stroke, and dementia. Stroke (2002) 0.91
A new instrument for outcome assessment in rehabilitation medicine: Spinal cord injury ability realization measurement index. Arch Phys Med Rehabil (2004) 0.90
Recovery of neurologic function following nontraumatic spinal cord lesions in Israel. Spine (Phila Pa 1976) (2004) 0.89
Spinal Cord Independence Measure, version III: applicability to the UK spinal cord injured population. J Rehabil Med (2009) 0.89
Changes in axonal morphology in experimental autoimmune neuritis as studied by high b-value q-space (1)H and (2)H DQF diffusion magnetic resonance spectroscopy. Magn Reson Med (2002) 0.88
Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging (2008) 0.88
Late results of surgery for herniated lumbar disk as related to duration of preoperative symptoms and type of herniation. Surg Neurol (2008) 0.88
Human-computer interaction in the administration and analysis of neuropsychological tests. Comput Methods Programs Biomed (2004) 0.88
Gender differences as an influence on patients' satisfaction rates in spinal surgery of elderly patients. Eur Spine J (2005) 0.87
Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis. Auton Neurosci (2011) 0.87
Early onset dementia: clinical and social aspects. Int Psychogeriatr (2009) 0.87
The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. Parkinsonism Relat Disord (2007) 0.87
Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background. Neurobiol Aging (2009) 0.86
Analysis of genetic polymorphisms in acetylcholinesterase as reflected in different populations. Curr Alzheimer Res (2005) 0.86
Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol. Int J Stroke (2011) 0.86
A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping. Brain (2005) 0.85
Gender effect on time to levodopa-induced dyskinesias. J Neurol (2011) 0.85
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. Parkinsonism Relat Disord (2012) 0.84
Computerized diagnosis of mild cognitive impairment. Alzheimers Dement (2007) 0.84
Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adults. Arch Gerontol Geriatr (2012) 0.84
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. J Neurol Sci (2004) 0.83
Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res (2005) 0.83
Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction. Mol Pharmacol (2003) 0.83
Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci (2002) 0.83
Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure. J Neurol Sci (2006) 0.82
Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome. Immunobiology (2003) 0.82
Prevalence of myotonic dystrophy in Israeli Jewish communities: inter-community variation and founder premutations. Am J Med Genet A (2003) 0.82
Epidemiology of dementia in Ashkelon: the influence of education. J Neurol (2003) 0.82
Diabetes and the brain: issues and unmet needs. Neurol Sci (2014) 0.82
Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke (2013) 0.82
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia (2010) 0.82
Inhibition of Ras attenuates the course of experimental autoimmune neuritis. J Neuroimmunol (2005) 0.81
Alzheimer's disease and vascular brain lesions. J Neurol Sci (2005) 0.81
Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy. EPMA J (2010) 0.81
Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor. J Neurol Sci (2004) 0.81
Hidden function of neuronal nicotinic acetylcholine receptor beta2 subunits in ganglionic transmission: comparison to alpha5 and beta4 subunits. J Neurol Sci (2005) 0.81
Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease. Seizure (2003) 0.80
Vascular dementia among elderly Arabs in Wadi Ara. J Neurol Sci (2002) 0.80
Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases. Neurotherapeutics (2009) 0.80
Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation. Isr Med Assoc J (2012) 0.80
Copolymer 1 (glatiramer acetate) in relapsing forms of multiple sclerosis: open multicenter study of alternate-day administration. Clin Neuropharmacol (2002) 0.79
Ropinirole in Gilles de la Tourette syndrome. Neurology (2004) 0.79
Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve. Muscle Nerve (2002) 0.79
Visual evoked potentials in idiopathic intracranial hypertension. Clin Neurol Neurosurg (2009) 0.79
Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia? Arch Neurol (2009) 0.79
Cerebral amyloid angiopathy impact on endothelium. Exp Gerontol (2012) 0.78
Survival after nontraumatic spinal cord lesions in Israel. Arch Phys Med Rehabil (2004) 0.78
Identification of histidine-rich glycoprotein, a potential autoantigen, in human and rat brain preparations. Ann N Y Acad Sci (2007) 0.78
Prefrontal compensatory mechanism may enable normal semantic memory performance in mild cognitive impairment (MCI). J Neuroimaging (2009) 0.78
Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains. Neuroreport (2007) 0.78
Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1). Epilepsy Behav (2013) 0.78
Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology. J Neurol (2010) 0.78
Cerebral vasomotor reactivity of patients with acute ischemic stroke: Cortical versus subcortical infarcts: an Israeli-Turkish collaborative study. J Neurol Sci (2007) 0.77
A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances. Int J Geriatr Psychiatry (2002) 0.77
Founder effect with variable age at onset in Arab families with Lafora disease and EPM2A mutation. Epilepsia (2007) 0.77
Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension. BMC Neurol (2011) 0.77
Outcomes in patients admitted for rehabilitation with spinal cord or cauda equina lesions following degenerative spinal stenosis. Disabil Rehabil (2005) 0.77
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia. Mov Disord (2006) 0.77
Acquired oculomotor nerve paresis with cyclic spasms in a young woman, a rare subtype of neuromyotonia. J Neuroophthalmol (2013) 0.77
[Depression precedes development of dementia]. Harefuah (2008) 0.77
Lay persons' beliefs and knowledge about Parkinson's disease: prevalence and socio-demographic correlates. Parkinsonism Relat Disord (2010) 0.77
Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis. Muscle Nerve (2003) 0.77
Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease. J Mol Neurosci (2014) 0.77
Vascular parkinsonism. Handb Clin Neurol (2007) 0.77
Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease. Mov Disord (2002) 0.77
Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.76
Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain (2008) 0.76
[Mild cognitive impairment (MCI): characteristics, risk factors and prevention]. Harefuah (2006) 0.76
Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 0.76